AstraZeneca Pharma India Ltd on Tuesday said it has signed a letter of intent (LoI) with Strand Life Sciences Pvt Ltd to explore opportunities to collaborate in healthcare in India.
Strand Life Sciences is a genomics research and diagnostics company and a subsidiary of Reliance Industries Ltd.
Further, AstraZeneca Pharma India, in a regulatory filing, clarified that it is not a related party to Strand, and the execution of the LoI does not constitute a related party transaction. It did not disclose further details about the LoI.
Published on November 17, 2026




